News

Deal Announcements

Paratek Pharmaceuticals Closes $40 Million Funding

Thursday, April 17, 2008 5:46:00 AM PDT | VentureDeal Staff
BOSTON, MA -- Paratek Pharmaceuticals, Inc. announced the closing of a new round of venture capital financing, raising $40 million in new investment.

Paratek is developing technology platforms to treat infectious diseases via TET antibacterials, non-antibacterial tetracyclines and multiple adaptational response-related treatments.

Aisling Capital led the round, which included D.E. Shaw Group, Nomura Phase4 Ventures, Novartis BioVenture Fund, HBM Bioventures and Hercules Technology Growth Capital.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1